State of Wyoming purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,589 shares of the company's stock, valued at approximately $154,000.
Other institutional investors have also added to or reduced their stakes in the company. Sound Income Strategies LLC increased its stake in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after acquiring an additional 204 shares during the last quarter. GAMMA Investing LLC increased its stake in Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after purchasing an additional 284 shares during the last quarter. Harbour Investments Inc. boosted its stake in shares of Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after purchasing an additional 619 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in Astera Labs during the 1st quarter worth approximately $48,000. Finally, Hazlett Burt & Watson Inc. increased its holdings in shares of Astera Labs by 1,670.0% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock worth $53,000 after acquiring an additional 835 shares during the period. Hedge funds and other institutional investors own 60.47% of the company's stock.
Insider Activity
In other Astera Labs news, CEO Jitendra Mohan sold 152,517 shares of the business's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the sale, the chief executive officer owned 450,001 shares of the company's stock, valued at approximately $76,648,670.33. The trade was a 25.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the business's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,832,489 shares of company stock worth $264,172,396. 12.50% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Several analysts have commented on ALAB shares. Wall Street Zen raised shares of Astera Labs from a "hold" rating to a "buy" rating in a research report on Saturday, August 16th. Evercore ISI raised their target price on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Morgan Stanley upped their price objective on shares of Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a research note on Friday, August 29th. Northland Securities downgraded shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective for the company. in a report on Tuesday, July 22nd. Finally, Stifel Nicolaus set a $145.00 target price on shares of Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Astera Labs presently has an average rating of "Moderate Buy" and an average price target of $142.00.
Read Our Latest Analysis on ALAB
Astera Labs Trading Up 14.5%
Shares of NASDAQ ALAB traded up $27.75 during trading hours on Monday, reaching $218.95. The stock had a trading volume of 7,369,005 shares, compared to its average volume of 4,960,852. The firm has a 50-day moving average of $141.64 and a 200-day moving average of $99.01. The firm has a market cap of $36.39 billion, a price-to-earnings ratio of 390.93, a PEG ratio of 4.85 and a beta of 1.46. Astera Labs, Inc. has a fifty-two week low of $36.85 and a fifty-two week high of $219.95.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's revenue for the quarter was up 149.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.
Astera Labs Profile
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Read More

Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.